Johnson & Johnson

JNJ

Current ValuationThe current P/E ratio is 29.61, above the reasonable range, cheaper than 13.89% of the time in the past 5 years, and the industry ranks 45/255, the industry Median -1.27.

29.61xP/E
Stock price$258.45Earnings per share$8.73

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
JNJUSJohnson & Johnson
29.61x18.50%$622.84B
RHHBYUSRoche
22.29x--$344.65B
RHHVFUSROCHE HOLDINGS AG
23.74x--$367.09B
NVSUSNOVARTIS AG
21.35x0.96%$272.33B
AZNUSAstraZeneca
23.77x--$248.34B
SNYNFUSSanofi
20.73x--$95.23B
SNYUSSanofi
20.96x23.01%$96.32B
MKKGYUSMerck
24.79x--$68.19B
CHGCYUSChugai Pharmaceutical
21.10x--$63.54B
RDYUSDr Reddys Laboratories
28.37x11.62%$10.22B
LGNDUSLigand Pharmac-B
29.64x14.77%$5.85B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.